Menu
Back to User profile » Dr Hai-Jun Zhang
Papers published by Dr Hai-Jun Zhang:
Upregulated Expression of Actin-Like 6A is a Risk Factor Affecting the Prognosis of Pancreatic Cancer
Zhang Z, Guo H, Zhang H
Cancer Management and Research 2021, 13:9467-9475
Published Date: 30 December 2021
Improvement of Diagnostic Accuracy for Pancreatic Cancer with Serum Lactate Dehydrogenase
Wang X, Wang C, Zhang H
Cancer Management and Research 2021, 13:4879-4886
Published Date: 21 June 2021
Effect of Glucose Variability on Pancreatic Cancer Through Regulation of COL6A1
Yu Q, Zhang Z, Zhang H
Cancer Management and Research 2021, 13:1291-1298
Published Date: 11 February 2021
Clinical Management of Risk of Radiation Pneumonia with Serum Markers During the Radiotherapy for Patients with Thoracic Malignant Tumors
Deng Y, Qiu T, Patel N, Zhou S, Xue T, Zhang H
Cancer Management and Research 2019, 11:10249-10256
Published Date: 5 December 2019
Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
Zhou S, Khanal S, Zhang H
Therapeutics and Clinical Risk Management 2019, 15:211-221
Published Date: 31 January 2019
Comparison of gefitinib as first- and second-line therapy for advanced lung adenocarcinoma patients with positive exon 21 or 19 del epidermal growth factor receptor mutation
Patel N, Wu P, Zhang H
Cancer Management and Research 2017, 9:243-248
Published Date: 28 June 2017
Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer
Zhang H
Drug Design, Development and Therapy 2016, 10:3867-3872
Published Date: 24 November 2016
Osimertinib making a breakthrough in lung cancer targeted therapy
Zhang H
OncoTargets and Therapy 2016, 9:5489-5493
Published Date: 6 September 2016
Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells
Liu P, Zhang H, Wu X, Guo L, Wang F, Xia G, Chen B, Yin H, Wang Y, Li X
OncoTargets and Therapy 2016, 9:5049-5059
Published Date: 12 August 2016
Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
Zhang H, Chen R, Yang S, Liu W, Li K, Zhang H, Zhu X, Chen B
OncoTargets and Therapy 2016, 9:4215-4224
Published Date: 11 July 2016
Onivyde for the therapy of multiple solid tumors
Zhang H
OncoTargets and Therapy 2016, 9:3001-3007
Published Date: 20 May 2016
Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors
Wu X, Zhang H, Salmani JMM, Fu R, Chen B
OncoTargets and Therapy 2016, 9:2935-2943
Published Date: 17 May 2016
Apatinib for molecular targeted therapy in tumor
Zhang H
Drug Design, Development and Therapy 2015, 9:6075-6081
Published Date: 13 November 2015
Urinary kallidinogenase for the treatment of cerebral arterial stenosis
Zhao L, Zhao Y, Wan Q, Zhang H
Drug Design, Development and Therapy 2015, 9:5595-5600
Published Date: 13 October 2015
Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer
Guo L, Zhang H, Shao W, Chen B
Drug Design, Development and Therapy 2015, 9:5491-5497
Published Date: 3 October 2015
Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system
Guo L, Zhang H, Wang F, Liu P, Wang Y, Xia G, Liu R, Li X, Yin H, Jiang H, Chen B
International Journal of Nanomedicine 2015, 10:4535-4547
Published Date: 16 July 2015
Effect of stent-assisted angioplasty on cognitive status and serum levels of amyloid beta in patients with intracranial and/or extracranial artery stenosis
Zhao L, Zhao Y, Zhang H
Neuropsychiatric Disease and Treatment 2015, 11:471-475
Published Date: 24 February 2015
Design real-time reversal of tumor multidrug resistance cleverly with shortened carbon nanotubes
Wu P, Li S, Zhang H
Drug Design, Development and Therapy 2014, 8:2431-2438
Published Date: 5 December 2014
The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics
Deng Y, Zhang H
International Journal of Nanomedicine 2013, 8:1835-1841
Published Date: 8 May 2013
Gambogic acid-loaded magnetic Fe3O4 nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1
Wang C, Zhang H, Chen Y, Shi F, Chen B
International Journal of Nanomedicine 2012, 7:781-787
Published Date: 14 February 2012
Daunorubicin-TiO2 nanocomposites as a “smart” pH-responsive drug delivery system
Zhang H, Wang C, Chen B, Wang X
International Journal of Nanomedicine 2012, 7:235-242
Published Date: 12 January 2012
Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
Chen Y, Wan Y, Wang Y, Zhang H, Jiao Z
International Journal of Nanomedicine 2011, 6:2321-2326
Published Date: 18 October 2011
Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles
Wang C, Zhang H, Chen B, Yin H, Wang W
International Journal of Nanomedicine 2011, 6:1929-1935
Published Date: 9 September 2011